Lens subluxation is more efficiently managed by phacoemulsification

Article

Lens subluxation and lens coloboma are better managed by phacoemulsification rather than manual small incision cataract surgery (MSICS).

Lens subluxation and lens coloboma are better managed by phacoemulsification rather than manual small incision cataract surgery (MSICS), reveals a study in The Journal of the British Contact Lens Association.

The investigation, led by Dr Saurabh Kamal, Guru Nanak Eye Centre, New Delhi, India, included a patient with bilateral isolated lens coloboma. In the left eye MSICS was performed and in the right eye phacoemulsification was conducted.

Lens extraction was indicated for cataract or subluxation by determining if visual function was adequately compromised.

The results revealed that nuclear rotation was disturbed due to a lack of zonules and lens coloboma presence. In the right eye the nucleus was broken during phacoemulsification. This allowed the successful implantation of a modified capsule tension ring.

In conclusion, eyes with lens coloboma are more at risk of complications during cataract surgery, so phacoemulsification is the safest and most successful treatment option.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.